Professor Paul Haber

Area Medical Director
Drug Health Services

Addiction Medicine, Central Clinical School

C39 - Royal Prince Alfred Hospital
The University of Sydney
NSW 2006 Australia

T: +61 2 9515 6419
F: +612 9515 8970
E:

Research interests

Alcoholic liver disease, drugs and alcohol, alcohol metabolism, hepatitis C

Current national competitive grants*

2011

Genetic risk factors for alcoholic cirrhosis - genome wide case control study
Seth D, Haber P, Nalpas B, Stickel F, Day C, Lumeng L, Morgan T, Whitfield J
NIH Research Support ($525,920 over 5 years)

* Grants administered through the University of Sydney

Keywords

Hepatology; Hepatitis; Gastroenterology; Alcohol; Substance abuse and addiction

Publications

2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008

2014

   
  • Morley, K., Haber, P., Tucker, P., Sitharthan, T. (2014), The Efficacy of an Opportunistic Cognitive Behavioral Intervention Package (OCB) on Substance Use and Comorbid Suicide Risk: A Multisite Randomized Controlled Trial. Journal of Consulting and Clinical Psychology. 82(1), 130-140. [Abstract]
  • Keane, F., Yao, T., Seelk, S., Gall, M., Chowdhury, S., Poplawski, S., Lai, J., Li, Y., Wu, W., Farrell, P., Vieira de Ribeiro, A., Osborne, B., Yu, D., Seth, D., Rahman, K., Haber, P., Topaloglu, A., Wang, C., Thomson, S., Hennessy, A., Prins, J., Twigg, S., McLennan, S., McCaughan, G., Bachovchin, W., Gorrell, M. (2014), Quantitation of fibroblast activation protein (FAP)-specific protease activity in mouse, baboon and human fluids and organs. FEBS Open Bio. 4, 43-54. [Abstract]

2013

   
  • Morley, K., Baillie, A., Sannibale, C., Teesson, M., Haber, P. (2013), Integrated care for comorbid alcohol dependence and anxiety and/or depressive disorder: study protocol for an assessor-blind, randomized controlled trial. Addiction Science & Clinical Practice. 8(1), 19. [Abstract]
  • Morley, K., Leung, S., Baillie, A., Haber, P. (2013), The efficacy and biobehavioural basis of baclofen in the treatment of alcoholic liver disease (BacALD): study protocol for a randomised controlled trial. Contemporary Clinical Trials. 36(2), 348-355. [Abstract]
  • Islam, M., Topp, L., Conigrave, K., Haber, P., White, A., Day, C. (2013), Sexually transmitted infections, sexual risk behaviours and perceived barriers to safe sex among drug users. Australian and New Zealand Journal of Public Health. 37(4), 311-315. [Abstract]
  • Alavi, M., Grebely, J., Micallef, M., Dunlop, A., Balcomb, A., Day, C., Treloar, C., Bath, N., Haber, P., Dore, G. (2013), Assessment and Treatment of Hepatitis C Virus Infection Among People Who Inject Drugs in the Opioid Substitution Setting: ETHOS Study. Clinical Infectious Diseases. 57 Suppl 2, S62-69. [Abstract]
  • Baillie, A., Sannibale, C., Stapinski, L., Teesson, M., Rapee, R., Haber, P. (2013), An investigator-blinded, randomized study to compare the efficacy of combined CBT for alcohol use disorders and social anxiety disorder versus CBT focused on alcohol alone in adults with comorbid disorders: the Combined Alcohol Social Phobia (CASP) trial protocol. BMC Psychiatry. 13(1), 199. [Abstract]
  • Islam, M., Topp, L., Conigrave, K., White, A., Haber, P., Day, C. (2013), Are primary health care centres that target injecting drug users attracting and serving the clients they are designed for? A case study from Sydney, Australia. The International Journal on Drug Policy. 24(4), 326-332. [Abstract]
  • Topp, L., Day, C., Wand, H., Deacon, R., van Beek, I., Haber, P., Shanahan, M., Rodgers, C., Maher, L. (2013), A randomised controlled trial of financial incentives to increase hepatitis B vaccination completion among people who inject drugs in Australia. Preventive Medicine. 57(4), 297-303. [Abstract]
  • Buckley, V., Razaghi, A., Haber, P. (2013), Predictors of neonatal outcomes amongst a methadone- and/or heroin-dependent population referred to a multidisciplinary Perinatal and Family Drug Health Service. The Australian & New Zealand Journal of Obstetrics & Gynaecology. 53(5), 464-470. [Abstract]
  • Lakshman, M., Amdur, R., Shah, R., Garige, M., Gong, M., Leckey, L., Varatharajalu, R., Redman, R., Seth, D., Haber, P., Hirsch, K. (2013), CYP2E1, Oxidative Stress, Post-translational Modifications and Lipid Metabolism. In: Cytochrome P450 2E1: Its Role in Disease and Drug Metabolism. (pp.199-234).Germany: Springer Science+Business Media.

2012

   
  • Islam, M., Topp, L., Conigrave, K., White, A., Reid, S., Grummett, S., Haber, P., Day, C. (2012), Linkage into specialist hepatitis C treatment services of injecting drug users attending a needle syringe program-based primary healthcare centre. Journal of Substance Abuse Treatment. 43(4), 440-445. [Abstract]
  • Black, K., Haber, P., Lintzeris, N. (2012), Offering incentives to drug-using women to take up contraception: The ethical and clinical issues. Addiction. , 1361-1362. [Abstract]
  • Deacon, R., Topp, L., Wand, H., Day, C., Rodgers, C., Haber, P., van Beek, I., Maher, L. (2012), Correlates of Susceptibility to Hepatitis B among People Who Inject Drugs in Sydney, Australia. Journal of Urban Health. 89(5), 769-778. [Abstract]
  • Gidding, H., Law, M., Amin, J., Ostapowicz, G., Weltman, M., Macdonald, G., Sasadeusz, J., Haber, P., George, J., Dore, G. (2012), Hepatitis C treatment outcomes in Australian clinics. Medical Journal of Australia. 196(10), 633-637. [Abstract]
  • Day, C., Demirkol, A., Tynan, M., Curry, K., Hines, S., Lintzeris, N., Haber, P. (2012), Individual versus team-based case-management for clients of opioid treatment services: An initial evaluation of what clients prefer. Drug and Alcohol Review. 31(4), 499-506. [Abstract]
  • Alavi, M., Grebely, J., Matthews, G., Petoumenos, K., Yeung, B., Day, C., Lloyd, A., Van Beek, I., Kaldor, J., Hellard, M., Dore, G., Haber, P. (2012), Impact of pegylated interferon alfa-2a treatment on mental health during recent hepatitis C virus infection. Journal of Gastroenterology and Hepatology. 27(5), 957-965. [Abstract]
  • Black, K., Stephens, C., Haber, P., Lintzeris, N. (2012), Unplanned pregnancy and contraceptive use in women attending drug treatment services. The Australian & New Zealand Journal of Obstetrics & Gynaecology. 52(2), 146-150. [Abstract]
  • Islam, M., Reid, S., White, A., Grummett, S., Conigrave, K., Haber, P. (2012), Opportunistic and continuing health care for injecting drug users from a nurse-run needle syringe program-based primary health-care clinic. Drug and Alcohol Review. , 114-115. [Abstract]
  • Schwarz, B., Haber, P. (2012), Detection and management of problem drinking in general practice. Medicine Today. 13(7), 44-52.
  • Taylor, L., Hutchinson, D., Rapee, R., Burns, L., Stephens, C., Haber, P. (2012), Clinical features and correlates of outcomes for high-risk, marginalized mothers and newborn infants engaged with a specialist perinatal and family drug health service. Obstetrics and Gynecology International. 2012, 867265. [Abstract]
  • Morley, K., Haber, P., Morgan, M., Samara, F. (2012), Pericyazine in the treatment of cannabis dependence in general practice: a naturalistic pilot trial. Substance Abuse and Rehabilitation. 3, 43-47.

2011

   
  • Lipworth, W., Wodak, A., Haber, P., Day, R. (2011), Why is disulfiram not on the PBS?. The Medical Journal of Australia. 195(7), 371-372. [Abstract]
  • Demirkol, A., Haber, P., Conigrave, K. (2011), Problem drinking - detection and assessment in general practice. Australian Family Physician. 40(8), 570-574. [Abstract]
  • Demirkol, A., Conigrave, K., Haber, P. (2011), Problem drinking - management in general practice. Australian Family Physician. 40(8), 576-582. [Abstract]
  • Grebely, J., Matthews, G., Hellard, M., Shaw, D., van Beek, I., Petoumenos, K., Alavi, M., Yeung, B., Haber, P., Lloyd, A., Kaldor, J., Dore, G. (2011), Adherence to treatment for recently acquired hepatitis C virus (HCV) infection among injecting drug users. Journal of hepatology. 55(1), 76-85. [Abstract]
  • Seth, D., Haber, P., Syn, W., Diehl, A., Day, C. (2011), Pathogenesis of Alcohol-induced Liver Disease - classical concepts and recent advances. Journal of gastroenterology and hepatology. 26(7), 1089-105. [Abstract]
  • Islam, M., Grummett, S., White, A., Reid, S., Day, C., Haber, P. (2011), A primary healthcare clinic in a needle syringe program may contribute to HIV prevention by early detection of incident HIV in an injecting drug user. Australian and New Zealand Journal of Public Health. , 294-295. [Abstract]
  • Haber, P. (2011), International perspectives in postgraduate medical training in addiction medicine. Substance Abuse. 32, 75-76. [Abstract]
  • Haber, P., Murnion, B. (2011), Training in addiction medicine in australia. Substance Abuse. 32(2), 115-119. [Abstract]
  • Day, C., Islam, M., White, A., Reid, S., Hayes, S., Haber, P. (2011), Development of a nurse-led primary healthcare service for injecting drug users in inner-city Sydney. Australian Journal of Primary Health. 17(1), 10-15. [Abstract]
  • Burns, L., Conroy, E., Moore, E., Hutchinson, D., Haber, P. (2011), Psychosocial characteristics and obstetric health of women attending a specialist substance use antenatal clinic in a large metropolitan hospital. International Journal of Pediatrics. 2011, 729237. [Abstract]
  • Haber, P. (2011), Gastrointestinal disorders related to alcohol and other drug use. In: Principles of Addiction Medicine: The Essentials. (pp.0).United States: Lippincott Williams & Wilkins.
  • Haber, P., Batey, R. (2011), Liver disorders related to alcohol and other drug use. In: Principles of Addiction Medicine: The Essentials. (pp.0).United States: Lippincott Williams & Wilkins.

2010

   
  • Teesson, M., Hall, W., Slade, T., Mills, K., Grove, R., Mewton, L., Baillie, A., Haber, P. (2010), Prevalence and correlates of DSM-IV alcohol abuse and dependence in Australia: findings of the 2007 National Survey of Mental Health and Wellbeing. Addiction (Abingdon, England). 105, 2085-94. [Abstract]
  • Baillie, A., Stapinski, L., Crome, E., Morley, K., Sannibale, C., Haber, P., Teesson, M. (2010), Some new directions for research on psychological interventions for comorbid anxiety and substance use disorders. Drug and Alcohol Review. 29(5), 518-524. [Abstract]
  • Sanson-Fisher, R., Brand, M., Shakeshaft, A., Haber, P., Day, C., Conigrave, K., Mattick, R., Lintzeris, N., Teesson, M. (2010), Forming a national multicentre collaboration to conduct clinical trials: increasing high-quality research in the drug and alcohol field. Drug and Alcohol Review. 29(5), 469-474. [Abstract]
  • Boonwaat, L., Haber, P., Levy, M., Lloyd, A. (2010), Establishment of a successful assessment and treatment service for Australian prison inmates with chronic hepatitis C. The Medical Journal of Australia. 192(9), 496-500. [Abstract]
  • Seth, D., Daly, A., Haber, P., Day, C. (2010), Patatin-like phospholipase domain containing 3: a case in point linking genetic susceptibility for alcoholic and nonalcoholic liver disease. Hepatology. 51(4), 1463-1465. [Abstract]
  • Grebely, J., Petoumenos, K., Matthews, G., Haber, P., Marks, P., Lloyd, A., Kaldor, J., Dore, G., Hellard, M. (2010), Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC Study. Drug and alcohol dependence. 107(2-3), 244-9. [Abstract]
  • Ramasamy, P., Lintzeris, N., Sutton, Y., Taylor, H., Day, C., Haber, P. (2010), The outcome of a rapid hepatitis B vaccination programme in a methadone treatment clinic. Addiction. 105(2), 329-334. [Abstract]
  • Dolan, K., Teutsch, S., Scheuer, N., Levy, M., Rawlinson, W., Kaldor, J., Lloyd, A., Haber, P. (2010), Incidence and risk for acute hepatitis C infection during imprisonment in Australia. European Journal of Epidemiology. 25(2), 143-148. [Abstract]
  • Seth, D., D'Souza El-Guindy, N., Apte, M., Mari, M., Dooley, S., Neuman, M., Haber, P., Kundu, G., Darwanto, A., de Villiers, W., Vonlaufen, A., Xu, Z., Phillips, P., Yang, S., Goldstein, D., Pirola, R., Wilson, J., Moles, A., Fernández, A., Colell, A., García-Ruiz, C., Fernández-Checa, J., Meyer, C., Meindl-Beinker, N. (2010), Alcohol, Signaling, and ECM Turnover. Alcoholism, clinical and experimental research. 34(1), 4-18. [Abstract]
  • Morley, K., Teesson, M., Sannibale, C., Baillie, A., Haber, P. (2010), Clinical Predictors of Outcome from an Australian Pharmacological Relapse Prevention Trial. Alcohol and alcoholism (Oxford, Oxfordshire). 45, 520-6. [Abstract]
  • Teutsch, S., Luciani, F., Scheuer, N., McCredie, L., Hosseiny, P., Rawlinson, W., Kaldor, J., Dore, G., Dolan, K., Ffrench, R., Lloyd, A., Haber, P., Levy, M. (2010), Incidence of primary hepatitis C infection and risk factors for transmission in an Australian prisoner cohort. BMC Public Health. 10, 633. [Abstract]
  • Dore, G., Hellard, M., Matthews, G., Grebely, J., Haber, P., Petoumenos, K., Yeung, B., Marks, P., van Beek, I., McCaughan, G., White, P., French, R., Rawlinson, W., Lloyd, A., Kaldor, J. (2010), Effective Treatment of Injecting Drug Users With Recently Acquired Hepatitis C Virus Infection. Gastroenterology. 138(1), 123-35.e1-2. [Abstract]

2009

   
  • Haber, P., Demirkol, A., Lange, K., Murnion, B. (2009), Management of injecting drug users admitted to hospital. Lancet. 374(9697), 1284-1293. [Abstract]
  • Leong, M., Murnion, B., Haber, P. (2009), Examination of Opioid Prescribing in Australia from 1992-2007. Internal medicine journal. 39(10), 676-81. [Abstract]
  • Matthews, G., Hellard, M., Haber, P., Yeung, B., Marks, P., Baker, D., McCaughan, G., Sasadeusz, J., White, P., Rawlinson, W., Lloyd, A., Kaldor, J., Dore, G. (2009), Characteristics and treatment outcomes among HIV-infected individuals in the Australian Trial in Acute Hepatitis C. Clinical Infectious Diseases. 48(5), 650-658. [Abstract]
  • Morley, K., Teesson, M., Sannibale, C., Haber, P. (2009), Sample bias from different recruitment strategies in a randomised controlled trial for alcohol dependence. Drug and Alcohol Review. 28(3), 222-229.
  • Haber, P., Lintzeris, N., Proude, E., Lopatko, O. (2009), Guidelines for the Treatment of Alcohol Problems. Australia: Commonwealth of Australia.
  • Haber, P., Neasham, K. (2009), Alcohol and Drug Abuse. In: Palliative Medicine. (pp.451-458).United States: Saunders.
  • Day, C., Haber, P. (2009), Managing drug dependence in people with hepatitis C. In: Hepatitis C: An Expanding Perspective. (pp.288-307).Australia: IP Communications.
  • Morley, K., Haber, P., Lintzeris, N. (2009), Pharmacotherapies for alcohol dependence. In: Guidelines for the Treatment of Alcohol Problems. (pp.93-106).Australia: Commonwealth of Australia.
  • Addolorato, G., Russell, M., Albano, E., Haber, P., Wands, J., Leggio, L. (2009), Understanding and Treating Patients With Alcoholic Cirrhosis: An Update. Alcoholism-Clinical and Experimental Research. 33(7), 1136-1144. [Abstract]
  • Colagiuri, B., Morley, K., Boakes, R., Haber, P. (2009), Expectancy in double-blind placebo-controlled trials: an example from alcohol dependence. Psychotherapy and Psychosomatics. 78(3), 167-171. [Abstract]

2008

   
  • Lane, J., Proude, E., Conigrave, K., de Boer, J., Haber, P. (2008), Nurse-provided screening and brief intervention for risky alcohol consumption by sexual health clinic patients. Sexually transmitted infections. 84(7), 524-7. [Abstract]
  • Gong, M., Castillo, L., Redman, R., Garige, M., Hirsch, K., Azuine, M., Amdur, R., Seth, D., Haber, P., Lakshman, M. (2008), Down-regulation of liver Galbeta1, 4GlcNAc alpha2, 6-sialyltransferase gene by ethanol significantly correlates with alcoholic steatosis in humans. Metabolism: Clinical and Experimental. 57(12), 1663-1668. [Abstract]
  • Dore, G., Haber, P. (2008), Tell me it ain't so: Patient-to-patient transmission of hepatitis C in an endoscopy clinic. Hepatology (Baltimore, Md.). 48(4), 1333-5. [Abstract]
  • Wurst, F., Haber, P., Wiesbeck, G., Watson, B., Wallace, C., Whitfield, J., Halter, C., Weinmann, W., Conigrave, K. (2008), Assessment of alcohol consumption among hepatitis C-positive people receiving opioid maintenance treatment using direct ethanol metabolites and self-report: a pilot study. Addiction biology. 13(0), 416-22. [Abstract]
  • Neuman, M., Sha, K., Esguerra, R., Zakhari, S., Winkler, R., Hilzenrat, N., Wyse, J., Cooper, C., Seth, D., Gorrell, M., Haber, P., McCaughan, G., Leo, M., Lieber, C., Voiculescu, M., Buzatu, E., Ionescu, C., Dudas, J., Saile, B., Ramadori, G. (2008), Inflammation and repair in viral hepatitis C. Digestive Diseases and Sciences. 53(6), 1468-1487. [Abstract]
  • Richardson, K., Baillie, A., Reid, S., Morley, K., Teesson, M., Sannibale, C., Weltman, M., Haber, P. (2008), Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?. Addiction. 103(6), 953-959. [Abstract]
  • Lintzeris, N., Lee, S., Scopelliti, L., Mabbutt, J., Haber, P. (2008), Unplanned admissions to two Sydney public hospitals after naltrexone implants. The Medical Journal of Australia. 188(8), 441-444. [Abstract]
  • Seth, D., Hogg, P., Gorrell, M., McCaughan, G., Haber, P. (2008), Direct effects of alcohol on hepatic fibrinolytic balance: implications for alcoholic liver disease. Journal of hepatology. 48(4), 614-627. [Abstract]
  • Thomson, C., Morley, K., Teesson, M., Sannibale, C., Haber, P. (2008), Issues with recruitment to randomised controlled trials in the drug and alcohol field: a literature review and Australian case study. Drug and alcohol review. 27(2), 115-122. [Abstract]
  • Williams, G., Daly, M., Proude, E., Kermode, S., Davis, M., Barling, J., Haber, P. (2008), The influence of alcohol and tobacco use in orthopaedic inpatients on complications of surgery. Drug and Alcohol Review. 27(1), 55-64. [Abstract]
  • Proude, E., Conigrave, K., Britton, A., Haber, P. (2008), Improving alcohol and tobacco history taking by junior medical officers. Alcohol and alcoholism. 43(3), 320-325. [Abstract]